Works matching IS 15228517 AND DT 2023 AND VI 25 AND IP 6


Results: 22
    1
    2
    3
    4

    What is a glioblastoma?

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1015, doi. 10.1093/neuonc/noad044
    By:
    • Lassman, Andrew B;
    • Bent, Martin J van den
    Publication type:
    Article
    5

    Society News.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1198, doi. 10.1093/neuonc/noad077
    Publication type:
    Article
    6
    7

    Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1085, doi. 10.1093/neuonc/noac285
    By:
    • Sampson, John H;
    • Achrol, Achal Singh;
    • Aghi, Manish K;
    • Bankiewicz, Krystof;
    • Bexon, Martin;
    • Brem, Steven;
    • Brenner, Andrew;
    • Chandhasin, Chandtip;
    • Chowdhary, Sajeel;
    • Coello, Melissa;
    • Ellingson, Benjamin M;
    • Floyd, John R;
    • Han, Seunggu;
    • Kesari, Santosh;
    • Mardor, Yael;
    • Merchant, Fahar;
    • Merchant, Nina;
    • Randazzo, Dina;
    • Vogelbaum, Michael;
    • Vrionis, Frank
    Publication type:
    Article
    8
    9

    Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1100, doi. 10.1093/neuonc/noac253
    By:
    • Dean, Jamie A;
    • Tanguturi, Shyam K;
    • Cagney, Daniel;
    • Shin, Kee-Young;
    • Youssef, Gilbert;
    • Aizer, Ayal;
    • Rahman, Rifaquat;
    • Hammoudeh, Lubna;
    • Reardon, David;
    • Lee, Eudocia;
    • Dietrich, Jorg;
    • Tamura, Kaoru;
    • Aoyagi, Masaru;
    • Wickersham, Lacey;
    • Wen, Patrick Y;
    • Catalano, Paul;
    • Haas-Kogan, Daphne;
    • Alexander, Brian M;
    • Michor, Franziska
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1017, doi. 10.1093/neuonc/noad002
    By:
    • Ellingson, Benjamin M;
    • Wen, Patrick Y;
    • Chang, Susan M;
    • van den Bent, Martin;
    • Vogelbaum, Michael A;
    • Li, Gang;
    • Li, Shanpeng;
    • Kim, Jiyoon;
    • Youssef, Gilbert;
    • Wick, Wolfgang;
    • Lassman, Andrew B;
    • Gilbert, Mark R;
    • Groot, John F de;
    • Weller, Michael;
    • Galanis, Evanthia;
    • Cloughesy, Timothy F
    Publication type:
    Article
    16
    17
    18
    19
    20

    Association of circulating markers with cognitive decline after radiation therapy for brain metastasis.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1123, doi. 10.1093/neuonc/noac262
    By:
    • Huntoon, Kristin;
    • Anderson, S Keith;
    • Ballman, Karla V;
    • Twohy, Erin;
    • Dooley, Katharine;
    • Jiang, Wen;
    • An, Yi;
    • Li, Jing;
    • Roemeling, Christina von;
    • Qie, Yaqing;
    • Ross, Owen A;
    • Cerhan, Jane H;
    • Whitton, Anthony C;
    • Greenspoon, Jeffrey N;
    • Parney, Ian F;
    • Ashman, Jonathan B;
    • Bahary, Jean-Paul;
    • Hadjipanayis, Constantinos;
    • Urbanic, James J;
    • Farace, Elana
    Publication type:
    Article
    21
    22

    Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, "window-of-opportunity" study.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1113, doi. 10.1093/neuonc/noac263
    By:
    • Moreno, Victor;
    • Sepúlveda, Juan Manuel;
    • Reardon, David A;
    • Pérez-Núñez, Ángel;
    • León, Pedro González;
    • Hanna, Bishoy;
    • Filvaroff, Ellen;
    • Aronchik, Ida;
    • Chang, Henry;
    • Amoroso, Barbara;
    • Zuraek, Marlene;
    • Sanchez-Perez, Tania;
    • Mendez, Cristina;
    • Stephens, Daniel;
    • Nikolova, Zariana;
    • Vogelbaum, Michael A
    Publication type:
    Article